Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
37- 10.13After-hours26.10.14 05:21424B3Offering#●●●#●●●
BioStem Technologies, Inc.
BioStem Technologies is registering the resale of up to 2,224,270 shares of common stock following a private placement agreement dated September 29, 2026. This offering includes 735,296 shares of common stock, along with Series A and B warrants (735,296 shares each) and placement agent warrants (18,382 shares). The company will not receive proceeds from the resale of these shares, but will receive cash proceeds upon the exercise of the warrants.…more
$1.57-0.63%vs prev closeView filingShare
- 10.13Pre-market26.10.13 13:15filedEFFECTOther
BioStem Technologies, Inc.
BioStem Technologies, Inc.'s registration statement (File No. 333-299282) was declared effective by the SEC on October 9, 2026. This effectiveness allows the company to proceed with the issuance and offering of the securities described in the filing.…more
$1.57-0.63%vs prev closeView filingShare - 10.9After-hours26.10.10 05:304Ownership
BioStem Technologies, Inc.
Insider Andrew Smith-Van Vurst of BioStem Technologies, Inc. reported a change in beneficial ownership of securities as of October 7, 2026. This filing serves as the official disclosure of insider equity movement via Form 4.…more
$1.57-0.63%vs prev closeView filingShare
36 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.8Pre-market26.10.08 20:00#●●●#●●●#●●●
BioStem Technologies Executives Invest $1 Million in Company Stock
BioStem Technologies' CEO and COO have exercised stock options to invest $1 million in the company. This move reflects management's confidence in the firm's growth prospects and provides capital to support expanded hospital commercial operations.…more
$1.57-0.63%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.2After-hours26.10.03 06:30
●●●●●●●● ●●●●● ●●●●●●
BioStem Technologies has filed a prospectus with the SEC for the resale of up to 2.2 million shares by existing stockholders. This filing may lead to potential share dilution concerns due to the increase in available market supply.…more
$1.57-0.63%vs prev closeShareBenzinga - 10.1Pre-market26.10.01 20:00
●●●●●●●● ●●●●● ●●●●●●
BioStem Technologies has secured one new patent and four notices of allowance in the U.S. and Mexico for its placental and umbilical cord tissue technologies. This expansion strengthens the company's intellectual property protection for its wound care and joint treatment product lines.…more
$1.57-0.63%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report